Riccardo Ponzone

Summary

Affiliation: Institute for Cancer Research and Treatment
Country: Italy

Publications

  1. doi request reprint Aromatase inhibitors for breast cancer: different structures, same effects?
    Riccardo Ponzone
    Gynaecological Oncology, Institute for Cancer Research and Treatment IRCC and ASO Ordine Mauriziano, University of Turin, Turin, Italy
    Endocr Relat Cancer 15:27-36. 2008
  2. ncbi request reprint Sentinel node dissection as definitive treatment for node negative breast cancer patients
    R Ponzone
    Academic Gynaecological Oncology Unit, Institute for Cancer Research and Treatment IRCC of Candiolo, Mauriziano Umberto I Hospital, Largo Turati 62, 10128 Turin, Italy
    Eur J Surg Oncol 29:703-6. 2003
  3. ncbi request reprint Comparison of two models for the prediction of nonsentinel node metastases in breast cancer
    Riccardo Ponzone
    Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment of Candiolo, Strada Provinciale 142, 10060 Candiolo, Turin, Italy
    Am J Surg 193:686-92. 2007
  4. ncbi request reprint Selected highlights from the 27th San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 8-11 December 2004
    Riccardo Ponzone
    Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment IRCC, Strada Provinciale 142, 10060 Candiolo, Turin, Italy
    Expert Opin Pharmacother 6:1257-67. 2005
  5. ncbi request reprint Vaginal oestrogen therapy after breast cancer: is it safe?
    Riccardo Ponzone
    Academic Department of Gynaecological Oncology, University of Turin, Mauriziano Umberto I Hospital of Turin and Institute for Cancer Research and Treatment of Candiolo, Largo Turati 62, Turin 10129, Italy
    Eur J Cancer 41:2673-81. 2005
  6. ncbi request reprint Pathological classification of ductal carcinoma in situ of the breast correlates with surgical treatment and may be predicted by mammography
    Riccardo Ponzone
    Academic Division of Gynaecological Oncology, Institute for Cancer Research and Treatment IRCC of Candiolo, University of Turin, Azienda Sanitaria Ospedaliera Ordine Mauriziano, 10060 Candiolo, Turin, Italy
    Breast 16:495-502. 2007
  7. ncbi request reprint Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer
    R Ponzone
    Academic Units of Gynaecological Oncology, University of Turin, Institute for Cancer Research and Treatment IRCC of Candiolo, A S O Ordine Mauriziano, Turin, Italy
    Ann Oncol 17:1631-6. 2006
  8. doi request reprint Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer
    Riccardo Ponzone
    Gynecological Oncology, University of Turin, Institute for Cancer Research and Treatment of Candiolo, Turin, Italy
    J Clin Oncol 27:5547-51. 2009
  9. doi request reprint Clinical and radiological predictors of nipple-areola complex involvement in breast cancer patients
    Marta D'Alonzo
    Academic Division of Gynecological Oncology, University of Turin, A O Ordine Mauriziano, Largo Turati 62, 110128 Turin, Italy
    Eur J Cancer 48:2311-8. 2012
  10. ncbi request reprint Mirtazapine for the treatment of hot flushes in breast cancer survivors: a prospective pilot trial
    Nicoletta Biglia
    Department of Gynaecological Oncology, University of Turin, Mauriziano Umberto I Hospital, Turin, Italy
    Breast J 13:490-5. 2007

Collaborators

Detail Information

Publications49

  1. doi request reprint Aromatase inhibitors for breast cancer: different structures, same effects?
    Riccardo Ponzone
    Gynaecological Oncology, Institute for Cancer Research and Treatment IRCC and ASO Ordine Mauriziano, University of Turin, Turin, Italy
    Endocr Relat Cancer 15:27-36. 2008
    ....
  2. ncbi request reprint Sentinel node dissection as definitive treatment for node negative breast cancer patients
    R Ponzone
    Academic Gynaecological Oncology Unit, Institute for Cancer Research and Treatment IRCC of Candiolo, Mauriziano Umberto I Hospital, Largo Turati 62, 10128 Turin, Italy
    Eur J Surg Oncol 29:703-6. 2003
    ..Negative sentinel node may predict tumour-free axillary nodes in breast cancer. We report the performance of sentinel node dissection at our Institution...
  3. ncbi request reprint Comparison of two models for the prediction of nonsentinel node metastases in breast cancer
    Riccardo Ponzone
    Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment of Candiolo, Strada Provinciale 142, 10060 Candiolo, Turin, Italy
    Am J Surg 193:686-92. 2007
    ..It is debated whether all patients with a positive sentinel node dissection (SLND) should be submitted to axillary lymph node dissection (ALND). Models have been developed to estimate the likelihood of nonsentinel node (non-SLN) metastases...
  4. ncbi request reprint Selected highlights from the 27th San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 8-11 December 2004
    Riccardo Ponzone
    Academic Division of Gynecological Oncology, Institute for Cancer Research and Treatment IRCC, Strada Provinciale 142, 10060 Candiolo, Turin, Italy
    Expert Opin Pharmacother 6:1257-67. 2005
    ..The most promising data from translational research have also been included, with particular regard to those who will most likely influence the management of breast cancer patients in the future...
  5. ncbi request reprint Vaginal oestrogen therapy after breast cancer: is it safe?
    Riccardo Ponzone
    Academic Department of Gynaecological Oncology, University of Turin, Mauriziano Umberto I Hospital of Turin and Institute for Cancer Research and Treatment of Candiolo, Largo Turati 62, Turin 10129, Italy
    Eur J Cancer 41:2673-81. 2005
    ..Further research is warranted to confirm whether vaginal estrogens are safe in symptomatic breast cancer patients who are non-responsive to alternative treatments...
  6. ncbi request reprint Pathological classification of ductal carcinoma in situ of the breast correlates with surgical treatment and may be predicted by mammography
    Riccardo Ponzone
    Academic Division of Gynaecological Oncology, Institute for Cancer Research and Treatment IRCC of Candiolo, University of Turin, Azienda Sanitaria Ospedaliera Ordine Mauriziano, 10060 Candiolo, Turin, Italy
    Breast 16:495-502. 2007
    ..We suggest that pathological features of DCIS are associated with surgical outcome and may be predicted by mammography...
  7. ncbi request reprint Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer
    R Ponzone
    Academic Units of Gynaecological Oncology, University of Turin, Institute for Cancer Research and Treatment IRCC of Candiolo, A S O Ordine Mauriziano, Turin, Italy
    Ann Oncol 17:1631-6. 2006
    ....
  8. doi request reprint Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer
    Riccardo Ponzone
    Gynecological Oncology, University of Turin, Institute for Cancer Research and Treatment of Candiolo, Turin, Italy
    J Clin Oncol 27:5547-51. 2009
    ..The aim of axillary reverse mapping (ARM) is to preserve arm lymphatics in patients with breast cancer who underwent surgical axillary staging...
  9. doi request reprint Clinical and radiological predictors of nipple-areola complex involvement in breast cancer patients
    Marta D'Alonzo
    Academic Division of Gynecological Oncology, University of Turin, A O Ordine Mauriziano, Largo Turati 62, 110128 Turin, Italy
    Eur J Cancer 48:2311-8. 2012
    ..Nipple-areola sparing mastectomy (NSM) is increasingly used in patients with non-locally advanced breast carcinoma. Literature data on the preoperative assessment of the nipple-areola complex (NAC) are inconsistent...
  10. ncbi request reprint Mirtazapine for the treatment of hot flushes in breast cancer survivors: a prospective pilot trial
    Nicoletta Biglia
    Department of Gynaecological Oncology, University of Turin, Mauriziano Umberto I Hospital, Turin, Italy
    Breast J 13:490-5. 2007
    ..The more frequent side effect was somnolence. A sizeable compiliance problem has been observed due to the reluctance to take antidepressant drugs and to side effects...
  11. ncbi request reprint Personal use of HRT by postmenopausal women doctors and doctors' wives in the north of Italy
    Nicoletta Biglia
    Gynecological Oncology Department, University of Turin, Mauriziano Umberto I Hospital, Turin, Italy
    Gynecol Endocrinol 18:165-74. 2004
    ..This is in contrast with the very low prevalence of use in the general population and may lead, in the near future, to a larger use of HRT in Italy...
  12. doi request reprint Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study
    Nicoletta Biglia
    Department of Oncological Gynaecology, University of Turin, Institute for Cancer Research and Treatment of Candiolo IRCC, Turin, Italy
    Gynecol Endocrinol 26:404-12. 2010
    ..The increase of serum estrogens levels during treatment with vaginal estrogen at these dosages is minimal...
  13. doi request reprint Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues
    Daniela Cimino
    Institute for Cancer Research and Treatment, Unit of Gynecological Oncology, University of Turin Medical School, Candiolo, Turin, Italy
    Int J Cancer 123:1327-38. 2008
    ..This work provides a novel set of genes that could be used as independent prognostic markers and potential drug targets for breast cancer...
  14. doi request reprint Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight
    Nicoletta Biglia
    Department of Gynaecological Oncology, University of Turin, Mauriziano Umberto I Hospital and Institute for Cancer Research and Treatment of Candiolo IRCC, Turin, Italy
    J Sex Med 7:1891-900. 2010
    ..Abrupt estrogen deficiency following chemotherapy and/or hormonal therapy plays an important role in worsening of sexuality...
  15. ncbi request reprint Antihormones in prevention and treatment of breast cancer
    Riccardo Ponzone
    Academic Unit of Gynaecological Oncology, University of Turin, Institute for Cancer Research and Treatment IRCC of Candiolo and A S O Ordine Mauriziano, Turin, Italy
    Ann N Y Acad Sci 1089:143-58. 2006
    ..Furthermore, it is likely that treatment tailoring will be increased by the definition of patient subgroups that could derive larger benefits from AIs (progesterone receptor-negative, HER-2-overexpressing) or other new drugs...
  16. ncbi request reprint Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial
    Nicoletta Biglia
    Gynaecological Oncology Department, University of Turin, Mauriziano Umberto I Hospital, Largo Turati 62, 10128 Turin, Italy
    Maturitas 54:181-92. 2006
    ..To describe the prevalence of hormone replacement therapy (HT) use by postmenopausal women doctors and doctors' wives in Italy and to explore the relationship between their personal characteristics and HT use...
  17. ncbi request reprint Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival
    Christian Sfiligoi
    Institute for Cancer Research and Treatment, Laboratory of Gynecological Oncology, Str Prov 142, 10060 Candiolo, Turin, Italy
    Int J Cancer 103:466-74. 2003
    ..In ZR75.1 and T47D cells, expression of ANG2 mRNA was increased up to 10-fold by treatment with estrogen within 24 hr. Although preliminary, these data suggest a possible role of ANG2 as a prognostic factor for primary breast cancer...
  18. ncbi request reprint Menopause after breast cancer: a survey on breast cancer survivors
    Nicoletta Biglia
    Academic Department of Gynecological Oncology, University of Turin, Mauriziano Umberto I degrees Hospital and Institute for Cancer Research and Treatment of Candiolo, Turin, Italy
    Maturitas 45:29-38. 2003
    ..Due to the younger age and the ever wider use of adjuvant chemotherapy and antiestrogens, menopausal symptoms are a frequent cause of concern for breast cancer patients...
  19. ncbi request reprint Hormone replacement therapy in cancer survivors
    Nicoletta Biglia
    Academic Department of Gynaecological Oncology, Institute for Cancer Research and Treatment IRCC, University of Turin, Candiolo, Largo Turati 62, 10128 Torino, Italy
    Maturitas 48:333-46. 2004
    ..The purpose of this paper is to review biological and clinical evidences in favour and against HRT use in the different tumours and to propose an algorithm that can help choosing the treatment for the single woman...
  20. pmc Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer
    Valentina Rossi
    Division of Medical Oncology, Fondazione del Piemonte per l Oncologia Institute for Cancer Research and Treatment, Candiolo, Italy
    Oncologist 17:1418-25. 2012
    ..We compared the clinical outcomes of operable breast cancer patients stratified according to a common HER-2 testing algorithm...
  21. doi request reprint Nipple-areola complex sparing mastectomy with periareolar pexy for breast cancer patients with moderately ptotic breasts
    Alessandro Rivolin
    Gynecological Oncology Unit, Institute for Cancer Research and Treatment IRCC of Candiolo, Fondazione del Piemonte per L Oncologia, Turin, Italy
    J Plast Reconstr Aesthet Surg 65:296-303. 2012
    ..Patients selection criteria and complication rates of PP-NSM were prospectively recorded and compared with those of the classical NSM...
  22. doi request reprint Correlations between diffusion-weighted imaging and breast cancer biomarkers
    Laura Martincich
    Unit of Radiology, Institute for Cancer Research and Treatment IRCC, Strada Provinciale 142, 10060, Candiolo, Turin, Italy
    Eur Radiol 22:1519-28. 2012
    ..We evaluated whether the apparent diffusion coefficient (ADC) provided by diffusion-weighted imaging (DWI) varies according to biological features in breast cancer...
  23. doi request reprint Variation of breast vascular maps on dynamic contrast-enhanced MRI after primary chemotherapy of locally advanced breast cancer
    Laura Martincich
    Unit of Diagnostic Imaging, Institute for Cancer Research and Treatment, Candiolo, Turin, Italy
    AJR Am J Roentgenol 196:1214-8. 2011
    ..The purpose of this article is to assess changes in breast vascular maps on dynamic contrast-enhanced MRI (DCE-MRI) after primary chemotherapy in patients with locally advanced breast cancer (LABC)...
  24. ncbi request reprint Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens
    Nicoletta Biglia
    Academic Department of Gynaecological Oncology, Institute for Cancer Research and Treatment of Candiolo, University of Turin, Mauriziano Umberto 1st Hospital, Turin, Italy
    Maturitas 45:283-91. 2003
    ..During the menopause, levels of SHBG, IGF-I and IGFBPs are significantly modified by the use of different HRT regimens...
  25. ncbi request reprint The 41st Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, USA, 13-17 May, 2005
    Filippo Montemurro
    Unit of Medical Oncology, Institute for Cancer Research and Treatment, IRCC Candiolo, Strada Provinciale 142, 10060 Candiolo, Turin, Italy
    Expert Opin Pharmacother 6:2907-21. 2005
    ..However, at present, for most of the diseases, improvements brought about by the newer therapies are small, although clinically meaningful. This review will briefly address some of the most interesting data presented at ASCO 2005...
  26. ncbi request reprint Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors
    N Biglia
    Academic Gynaecological Oncology Department, University of Turin, IRCC Institute for Cancer Research and Treatment of Candiolo, Turin and Mauriziano Umberto I Hospital, Largo Turati 62, Torino 10128, Italy
    Maturitas 52:78-85. 2005
    ..To evaluate the efficacy and tolerability of long-term treatment with venlafaxine at low dose for the reduction of vasomotor symptoms in breast cancer survivors...
  27. ncbi request reprint How to manage the menopause following therapy for breast cancer. is raloxifene a safe alternative?
    P Sismondi
    Department of Gynecological Oncology, University of Turin, Mauriziano Umberto I Hospital, c so G Ferraris 122, 10128, Turin, Italy
    Eur J Cancer 36:S74-6. 2000
    ..For symptomatic patients, the association of raloxifene with different drugs which have demonstrated efficacy in the control of vasomotor symptoms is now under evaluation...
  28. ncbi request reprint Concurrent radiotherapy does not affect adjuvant CMF delivery but is associated with increased toxicity in women with early breast cancer
    F Montemurro
    Unit of Medical Oncology, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
    J Chemother 18:90-7. 2006
    ..Our retrospective analysis suggests that concurrent-RT has no impact on optimal CMF delivery, but it increases the burden of CMF-related toxicity...
  29. doi request reprint Loco-regional therapy and breast cancer survival: searching for a link
    Riccardo Ponzone
    Division of Gynecological Oncology, Fondazione del Piemonte per L Oncologia, Turin, Italy
    Breast 22:510-4. 2013
    ....
  30. ncbi request reprint The influence of hormone replacement therapy on the pathology of breast cancer
    N Biglia
    Gynaecological Oncology Unit, Institute for Cancer Research and Treatment IRCC of Candiolo and Mauriziano Umberto I Hospital, University of Turin, Largo Turati 62, 10128 Turin, Italy
    Eur J Surg Oncol 31:467-72. 2005
    ..To assess whether the pathological characteristics of breast carcinomas arising in post-menopausal women who ever used hormonal replacement therapy (HRT) differ from those of post-menopausal patients who never used HRT...
  31. doi request reprint Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E
    N Biglia
    Department of Gynecological Oncology, University of Turin, Mauriziano Umberto I Hospital and Institute for Cancer Research and Treatment of Candiolo IRCC, Turin, Italy
    Climacteric 12:310-8. 2009
    ..The secondary objective was to evaluate the effect of the treatments on the quality of sleep and other aspects of the quality of life...
  32. ncbi request reprint Sentinel node biopsy for breast cancer: yes, less surgery is better surgery
    P Sismondi
    Academic Gynecological Oncology Unit, Institute for Cancer Research and Treatment IRCC of Candiolo, Turin, and Mauriziano Umberto 1st Hospital of Turin, Italy
    Eur J Gynaecol Oncol 24:107-12. 2003
    ..Many issues, some of which will be discussed in the light of our personal experience, still need to be tested in clinical controlled trials...
  33. ncbi request reprint Management of risk of breast carcinoma in postmenopausal women
    N Biglia
    Academic Department of Gynecological Oncology, Mauriziano Umberto I Hospital Torino and Institute for Cancer Research and Treatment I RCC of Candiolo, Turin, Italy
    Endocr Relat Cancer 11:69-83. 2004
    ..Chemoprevention with tamoxifen and with the new selective estrogen receptor modulators, namely raloxifene, is very promising and deserves a thorough discussion for all high-risk women...
  34. ncbi request reprint Quantitative real-time RT-PCR analysis of eight novel estrogen-regulated genes in breast cancer
    V Sorbello
    Laboratory of Oncological Gynecology, Institute for Cancer Research and Treatment, Candiolo, Turin, Italy
    Int J Biol Markers 18:123-9. 2003
    ....
  35. ncbi request reprint Breast cancer and hormone replacement therapy: putting the risk into perspective
    C Campagnoli
    Endocrinological Gynecology Unit, St Anna Hospital, Turin, Italy
    Gynecol Endocrinol 15:53-60. 2001
    ..However, the theoretical possibility exists that low doses of oral estrogens, plus a progestin providing progesterone-like effects only, will be shown to be associated with a limited breast cancer risk increase...
  36. ncbi request reprint HRT, breast and endometrial cancers: strategies and intervention options
    P Sismondi
    Department of Gynaecological Oncology, University of Turin, Italy
    Maturitas 32:131-9. 1999
    ..It is equally important that the best strategies for breast and endometrial surveillance in women commencing HRT be outlined, bearing in mind that the diffusion of hormonal therapies may be halted by unnecessary medical interventions...
  37. pmc Prostate-specific antigen in serum of women with breast cancer
    M Giai
    Department of Gynecologic Oncology, University of Turin, Italy
    Br J Cancer 72:728-31. 1995
    ....
  38. ncbi request reprint The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer
    George M Yousef
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
    Breast Cancer Res Treat 78:149-58. 2003
    ..Like other kallikreins, the KLK9 gene was found to be regulated by steroid hormones, mainly estrogens and progestins, in cancer cell lines...
  39. ncbi request reprint Progesterone receptor and human epidermal growth factor receptor 2 status: an independent influence on the efficacy of endocrine therapy in breast cancer?
    Riccardo Ponzone
    J Clin Oncol 24:1481-2; author reply 1482. 2006
  40. ncbi request reprint Role of Magnetic Resonance Imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy
    Laura Martincich
    UOA di Radiodiagnostica, Istituto per la Ricerca e la Cura del Cancro, Ordine Mauriziano di Torino, Candiolo Torino, Italy
    Radiol Med 106:51-8. 2003
    ..To evaluate if dynamic contrast enhanced magnetic resonance can predict the tumoural response in patients with breast cancer undergoing neoadjuvant chemotherapy...
  41. ncbi request reprint Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging
    Laura Martincich
    Department of Diagnostic Imaging, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
    Breast Cancer Res Treat 83:67-76. 2004
    ..We sought to investigate whether DCE-MRI could be used to predict histological response in patients undergoing primary chemotherapy (PCT) for breast cancer...
  42. ncbi request reprint Axillary reverse mapping in breast cancer: can we spare what we find?
    Riccardo Ponzone
    Ann Surg Oncol 15:390-1; author reply 392-3. 2008
  43. ncbi request reprint Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine
    Riccardo Ponzone
    J Natl Cancer Inst 96:883-4; author reply 884-5. 2004
  44. ncbi request reprint Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes
    Piero Sismondi
    Cattedra di Ginecologia Oncologica, Istituto per la Ricerca e la Cura del Cancro, Universita degli Studi di Torino, Candiolo, Italy
    Maturitas 57:50-5. 2007
    ..Our results underline the complexity of genomic responses to estrogen in breast cancer cells and strongly suggest that the molecular characterization of estrogen agonists and antagonists used in human therapy should be carefully studied...
  45. ncbi request reprint Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer
    Filippo Montemurro
    Unit of Medical Oncology, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
    Eur Radiol 17:1490-7. 2007
    ..608, p = 0.02). Based on our results, we suggest that lesions with intermediate-low suspicious DCE-MRI parameters may represent a subset of tumor with poor histopathological characteristics...
  46. ncbi request reprint Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality
    Riccardo Ponzone
    Cancer 94:579-80; author reply 581-3. 2002
  47. ncbi request reprint Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer
    George M Yousef
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, M5G 1X5 Canada
    Clin Chem 48:1241-50. 2002
    ..Like the genes that encode PSA and other kallikreins, the KLK5 gene was found to be regulated by steroid hormones in the BT-474 breast cancer cell line...
  48. ncbi request reprint Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells
    Claudio Scafoglio
    Dipartimento di Patologia Generale, Seconda Universita degli Studi di Napoli, Vico L De Crecchio 7, 80138 Naples, Italy
    J Cell Biochem 98:1163-84. 2006
    ....
  49. doi request reprint Patients with breast cancer are unlikely to benefit from prophylactic irradiation of the contralateral breast
    Riccardo Ponzone
    J Clin Oncol 26:1014-5; author reply 1015-6. 2008